Product correctly added to cart.

discount label
SB 202190
View 3D

Targetmol logo

SB 202190

CAS: 152121-30-7

Ref. TM-T2301

25mg
33.00 €
50mg
47.00 €
100mg
76.00 €
200mg
127.00 €
1ml*10 (DMSO)
47.00 €
Estimated delivery in United States, on Thursday 16 May 2024

Product Information

Name:
SB 202190
Synonyms:
  • FHPI, SB202190
  • 2,5-cyclohexadien-1-one, 4-[4-(4-fluorophenyl)-1,3-dihydro-5-(4-pyridinyl)-2H-imidazol-2-ylidene]-
  • 4-(4-Fluorophenyl)-2-(4-Hydroxyphenyl)-5-(4-Pyridyl)Imidazole
  • 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole
  • 4-[4-(4-Fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]phenol
  • 4-[4-(4-fluorophenyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl]phenol
  • 4-[5-(4-Fluorophenyl)-4-(pyridin-4-yl)-1H-imidazol-2-yl]phenol
  • Phenol, 4-[4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-
  • Sb 202190
  • Sb202190
  • See more synonyms
  • phenol, 4-[5-(4-fluorophenyl)-4-(4-pyridinyl)-1H-imidazol-2-yl]-
Description:

SB 202190 (FHPI) is a p38 MAPK inhibitor that inhibits p38α and p38β2 (IC50=50/100 nM) selectively and cell-permeably. SB 202190 has antitumor activity and also induces the differentiation of human embryonic stem cells into cardiomyocytes.

Brand:
Targetmol
Long term storage:
Notes:

Chemical properties

Molecular weight:
331.34
Formula:
C20H14FN3O
Purity:
99.84%
Color/Form:
Pale Yellow
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: TM-T2301 SB 202190

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".